Characterization of 1-methyl-4-[4'-amino]phenyl-1,2,3,6-tetrahydropyridine toxicity in the mouse.
Johannessen
J N
JN
Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD 20892.
Markey
S P
SP
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000031:analogs & derivatives; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000473:pathology; D001923:Brain Chemistry / Q000187:drug effects; D004298:Dopamine / Q000032:analysis; D020267:MPTP Poisoning; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D013329:Structure-Activity Relationship
D008996:Monoamine Oxidase Inhibitors; D010879:Piperazines; C043425:vanoxerine; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine